Many years after the introduction of the protected specimen brush (PSB) by Wimberley et al. as a tool to diagnose ventilator associated pneumonia (VAP), new sampling techniques have increased the controversy concerning the diagnosis of VAP. Agreement exists only on the high sensibility and low specificity of the clinical symptoms combined with imaging data. However, sampling methods, qualitative/quantitative microbiological evaluation and the value of “markers” still appear to be unresolved issues. Because a proven diagnosis is very rare, a more pragmatic approach to VAP diagnosis seems necessary. More specifically, the questions we must focus on include the following: ”Which patients with possible pneumonia or lower respiratory infection require antibiotic treatment ?” and “In which patients with possible/suspected VAP is empiric treatment not immediately necessary and for which of these patients can empiric treatment be limited or discontinued?”
Ventilator associated pneumonia (VAP): an impossible diagnosis? Call for a pragmatic approach / M. Langer, E.A. Haeusler. - In: MINERVA ANESTESIOLOGICA. - ISSN 0375-9393. - 75:10(2009 Oct), pp. 584-590.
Ventilator associated pneumonia (VAP): an impossible diagnosis? Call for a pragmatic approach
M. LangerPrimo
;
2009
Abstract
Many years after the introduction of the protected specimen brush (PSB) by Wimberley et al. as a tool to diagnose ventilator associated pneumonia (VAP), new sampling techniques have increased the controversy concerning the diagnosis of VAP. Agreement exists only on the high sensibility and low specificity of the clinical symptoms combined with imaging data. However, sampling methods, qualitative/quantitative microbiological evaluation and the value of “markers” still appear to be unresolved issues. Because a proven diagnosis is very rare, a more pragmatic approach to VAP diagnosis seems necessary. More specifically, the questions we must focus on include the following: ”Which patients with possible pneumonia or lower respiratory infection require antibiotic treatment ?” and “In which patients with possible/suspected VAP is empiric treatment not immediately necessary and for which of these patients can empiric treatment be limited or discontinued?”File | Dimensione | Formato | |
---|---|---|---|
Langer.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
51.09 kB
Formato
Adobe PDF
|
51.09 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.